{"id":"https://openalex.org/W2115647670","doi":"https://doi.org/10.1016/j.bmcl.2009.10.113","title":"Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor","display_name":"Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor","publication_year":2009,"publication_date":"2009-10-31","ids":{"openalex":"https://openalex.org/W2115647670","doi":"https://doi.org/10.1016/j.bmcl.2009.10.113","mag":"2115647670","pmid":"https://pubmed.ncbi.nlm.nih.gov/19945872"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2009.10.113","doi":"https://doi.org/10.1016/j.bmcl.2009.10.113","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.10.113","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111667404","display_name":"Jeff DeFalco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96690311","display_name":"Evotec (United States)","ror":"https://ror.org/01j538c21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130816","https://openalex.org/I96690311"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeff DeFalco","raw_affiliation_strings":["Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA. jeff.defalco@gmail.com","Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA. jeff.defalco@gmail.com","institution_ids":["https://openalex.org/I96690311"]},{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I96690311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050804947","display_name":"Daniel Steiger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96690311","display_name":"Evotec (United States)","ror":"https://ror.org/01j538c21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130816","https://openalex.org/I96690311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Steiger","raw_affiliation_strings":["Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I96690311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051895522","display_name":"Amy E. Gustafson","orcid":"https://orcid.org/0000-0003-0837-4560","observed_orcids":["https://orcid.org/0000-0003-0837-4560"]},"institutions":[{"id":"https://openalex.org/I96690311","display_name":"Evotec (United States)","ror":"https://ror.org/01j538c21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130816","https://openalex.org/I96690311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Gustafson","raw_affiliation_strings":["Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I96690311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074817413","display_name":"Daniel E. Emerling","orcid":"https://orcid.org/0000-0002-8754-9201","observed_orcids":["https://orcid.org/0000-0002-8754-9201"]},"institutions":[{"id":"https://openalex.org/I96690311","display_name":"Evotec (United States)","ror":"https://ror.org/01j538c21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130816","https://openalex.org/I96690311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E. Emerling","raw_affiliation_strings":["Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I96690311"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael G. Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96690311","display_name":"Evotec (United States)","ror":"https://ror.org/01j538c21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130816","https://openalex.org/I96690311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael G. Kelly","raw_affiliation_strings":["Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I96690311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041051375","display_name":"Matthew A. J. Duncton","orcid":"https://orcid.org/0000-0002-6007-7515","observed_orcids":["https://orcid.org/0000-0002-6007-7515"]},"institutions":[{"id":"https://openalex.org/I96690311","display_name":"Evotec (United States)","ror":"https://ror.org/01j538c21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130816","https://openalex.org/I96690311"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew A.J. Duncton","raw_affiliation_strings":["Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renovis, Inc. (a wholly-owned subsidiary of Evotec AG), Two Corporate Drive, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I96690311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041051375","https://openalex.org/A5111667404"],"corresponding_institution_ids":["https://openalex.org/I96690311"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.8962,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.90668929,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"1","first_page":"276","last_page":"279"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11584","display_name":"Biochemical Analysis and Sensing Techniques","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trpa1-receptor","display_name":"TRPA1 receptor","score":0.9330000281333923},{"id":"https://openalex.org/keywords/oximes","display_name":"oximes","score":0.8389999866485596},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9168015718460083},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.8548991680145264},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7018675208091736},{"id":"https://openalex.org/C2779648554","wikidata":"https://www.wikidata.org/wiki/Q182738","display_name":"Oxime","level":2,"score":0.6239006519317627},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.516472578048706},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4898547828197479},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4722418487071991},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4363185167312622},{"id":"https://openalex.org/C86811712","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Competitive antagonist","level":4,"score":0.41197049617767334},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23687273263931274},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000074025","descriptor_name":"TRPA1 Cation Channel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015220","descriptor_name":"Calcium Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050051","descriptor_name":"Transient Receptor Potential Channels","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D050051","descriptor_name":"Transient Receptor Potential Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050051","descriptor_name":"Transient Receptor Potential Channels","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2009.10.113","doi":"https://doi.org/10.1016/j.bmcl.2009.10.113","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2009.10.113","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:19945872","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19945872","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1965701201","https://openalex.org/W1996634599","https://openalex.org/W2005348655","https://openalex.org/W2009967312","https://openalex.org/W2014185236","https://openalex.org/W2020833052","https://openalex.org/W2035257142","https://openalex.org/W2039246411","https://openalex.org/W2062978707","https://openalex.org/W2099970064","https://openalex.org/W2102654149","https://openalex.org/W2107063571","https://openalex.org/W2109644936","https://openalex.org/W2109879418","https://openalex.org/W2113684190","https://openalex.org/W2120229762","https://openalex.org/W2164073806","https://openalex.org/W2169701996","https://openalex.org/W2180379209"],"related_works":["https://openalex.org/W4410237726","https://openalex.org/W1533390456","https://openalex.org/W2043150186","https://openalex.org/W1969228006","https://openalex.org/W2278364556","https://openalex.org/W4405662457","https://openalex.org/W2052362236","https://openalex.org/W2792252878","https://openalex.org/W4376868858","https://openalex.org/W2190564680"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}